Veracyte, Inc. (VCYT) is down 55.45 percent, losing $29.12 to $23.40 on Thursday. The sharp decline comes despite the company's improved third-quarter financial performance. Net income rose to $31.5 million, or $0.38 per share, from $19.1 million, or $0.24 per share, a year earlier. Total revenue increased 15.1 percent to $151.75 million from $131.87 million, supported by higher testing and product revenue.The stock is currently trading at $23.40, compared with the previous close of $52.52 on the Nasdaq. I ...